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Few studies examine the benefits from geriatric telepsychiatry in ru-
ral retirement communities. Objectives: 1. To demonstrate that using 
telepsychiatry (a) standard approaches to psychiatric evaluation would 
yield diagnoses in Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V); (b) psychotherapies and pharmacotherapy could be effectively 
administered. 2. To examine the relationships among cognition, mood, 
agitation and functions at baseline and the response to treatment over 
time. Design: Prospective longitudinal study. Measures: Geriatric De-
pression scale (GDS), Mini Mental State Exam (MMSE), Barthel Index 
(BI), Pittsburgh Agitation Scale (PAS). Setting: Video Teleconferencing. 
Interventions: Psychotherapy, psychopharmacology. Participants: 428 
Seniors over 55, met criteria for at least one DSM-V diagnosis. Results: 
Treatments were administered for a full range of psychiatric diagnoses 
and age-related medical conditions. The most frequently prescribed 
pharmacological agents were: antidepressants (78%) antipsychotics 
(64%), memory enhancers (38%). Participants (66%) received psycho-
therapy: individual (31%), couple (7%), family (13%). Variation in the 
MMSE scores were observed: 55% remained stable, 11% declined, 18% 
improved. GDS Scores improved from baseline to 26 weeks (p=0.02, 
d=0.99: 95% CI 0.39-1.56). PAS scores declined from baseline to 52 
weeks (McNemar’s S= 11.27, p=0.0008, d=1.17: 95% CI 0.63-1.68). 
Function (BI) at week 26 was not statistically significantly different from 
baseline (t(26)=1.66, p=0.11, d=0.65: 95%CI -0.16-1.42). Participants 
maintained independence (64.5%) at 52 weeks (McNemar’s S = 6.23, 
p=0.013, d=0.79: 95%CI 0.19-1.36) Conclusion: This study demonstrates 
the feasibility and benefit of providing a full complement of services via 
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1. Introduction
Telepsychiatry has proven feasible in a wide range of settings, across a complement of psychiatric treatments and in different ethnic groups [1,2]. Diag-
noses can be made reliably using a variety of assessment 
measures [2]. Comparisons with in-person care (IP) report 
benefits attributed to telepsychiatry: shortened hospital-
ization, better medication adherence, symptom reduction 
from treatment with evidenced based therapies [3,4].   
With respect to geriatric telepsychiatry, a recent sys-
tematic review described 68 publications which reflect the 
current state of knowledge [5]. Of these, 35% investigated 
neuropsychological testing, had small sample sizes [6,7] 
with a few exceptions [8,9] confirmed feasibility, satisfac-
tion and correlation between in person (IP) and videocon-
ferencing (VC). Another focus (26%) was clinical diag-
nosis and treatment of dementia in community dwelling 
patients using a variety of study designs (one randomized 
controlled trial (RCT), three crossover, four prospective, 
six descriptive and two non-controlled feasibility studies). 
The reliability of the clinical diagnosis of dementia via 
VC was not inferior to IP [10]. There was a high degree of 
compliance and satisfaction in the VC group. RCT found 
comparable improvement in cognition for both groups [11]. 
Only 10% studied nursing homes for a total of 367 par-
ticipants. Telepsychiatry in a rural setting was more cost 
effective for the physician in terms of time and travel than 
IP consultation [12]. Outpatient studies reported increased 
expenditures for both modalities [13] and even found VC 
to be more costly than IP due to the lack of collaboration 
of local physicians with follow up care [14]. Mixed results 
reflect different measurements, different venues, cultural 
variation and the general trend of increasing health care 
costs. Few papers provide results of psychotherapy: be-
havioral activation via VC was not inferior to IP (N = 241) 
[15], improvements gained by problems solving therapy 
for the depressed and low income persisted longer for VC 
than IP care (n=158) [16] and cognitive behavioral therapy 
improved sleep and mood (N=5) [17].
Our prospective longitudinal study collected data from 
all consecutive referrals meeting eligibility criteria. The 
assessments and treatment approaches are consistent with 
best practices in geriatric psychiatry. 
2. Objectives
The study goals are: (1) to examine the characteristics and 
diagnoses of the population referred for telepsychiatry, (2) 
to determine what types of interventions could feasibly be 
provided to the participants via this venue, (3) to examine 
the relationships between cognitive status, mood, agitation 




Forefront Telecare (FT) Inc. delivers behavioral health 
HIPAA-compliant TeleCare services to rural retirement 
facilities using high definition monitors and web cam. FT 
uses 13 technology products for its websites including 
WordPress (website construction), Vimeo (refined video 
production) and PHP (embedded server-side scripting 
ensuring maximum performance and non-interruptible 
functioning). FT identified the facilities in need of remote 
services, introduced the psychiatrist (SS) to their teams 
(nursing, social workers, internal medicine physicians and 
management) prior to scheduling the resident’s appoint-
ments for telepsychiatry in order to establish a collabora-
tive model of care known to improve outcomes [18]. Clini-
cal care was scheduled in response to resident needs at the 
request of onsite physicians and their colleagues. Prior to 
consultations, the in-house teams provided the psychia-
trist with information about the resident’s medical health 
(lab results, imaging reports). The telepsychiatry sessions 
were staffed by an on-site social worker who accompa-
nied the patient and family to the designated room for 
sessions with the “TV Doc.” and remained throughout the 
interview. New evaluations required 90 minutes and fol-
low up sessions 30 minutes. The psychiatrist would make 
recommendations for treatment and the onsite team would 
implement them. The research assessments were fixed at 
certain intervals as described in the measures section.
3.2 Participants
Participants were recruited and referred from 9 facili-
ties in central and northern Pennsylvania for psychiatric 
evaluation and treatment via telepsychiatry all completed 
by the first author (SS). Baseline and follow up visits oc-
curred from 2012 to 2015. Involvement was discontinued 
for the following reasons: 16 were discharged (4%), 7 had 
a lateral transfer to community care as telepsychiatry was 
ineffective (1.6%), 155 had a consultation only (36%) and 
87 died (20%). After these exclusions the final cohort was 
N=428. The Crozer Keystone Institutional Review Board 
approved the study and all participants, or their represen-
tatives provided informed consent.
3.3 Eligibility Criteria
The participants were eligible if they were age 55 or over 
and included regardless of race, socioeconomic group, 
DOI: https://doi.org/10.30564/jgm.v1i2.1840
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or pre-existing medical conditions. Participants were ex-
cluded if they were receiving face-to-face therapy in their 
local community. 
3.4 Measures 
The measures supplemented a complete psychiatric eval-
uation using Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) criteria. The measures selected are 
widely used, well validated, brief, and were administered 
at baseline and every 6 months thereafter by the psychia-
trist (SS). 
Geriatric Depression Scale (GDS) The 15-item version 
Geriatric Depression Scale (GDS) was administered with 
a cut point of ≥5 suggesting depression. Remission was 
considered when the score was <5 or 50% of the baseline 
value.
Mini-mental State Examination (MMSE) The Mini-Men-
tal State Exam is a test of global cognitive function. 
Scores range from 0-30. Commonly used cut scores for 
severity: normal 27-30; mild 21-26, moderate >10-20 and 
severe ≤ 10. 
Pittsburgh Agitation Scale (PAS) [19] tests four groups 
of behaviors: aberrant vocalizations, aggression, resisting 
care and agitation rated on a four point Likert scale with 
a maximum total score of 16. Participants with scores of 
8 or more required treatment. Remission was defined as a 
50% or more decrease from baseline.
Barthel Index (Activities of Daily Living) [20] is a mea-
sure of activities of daily living (ADLs) scored from 0-100. 
A clinically significant decline in independence was de-
fined as a change from independence (≥50) to dependence 
(<50) or a decline of 10% in the mean score from base-
line.  
3.5 Statistical Analysis 
The analysis consists primarily of descriptives (i.e. means 
with standard deviation and frequencies/percent). Paramet-
ric analyses included t-test for comparison of a binary and 
continuous measures, ANOVA for comparison of a categor-
ical and a continuous measure. To assess for relationships 
over repeated time points, we used the paired t-test for 
continuous measures, McNemar’s test for binary measures. 
Cohen’s d Effect sizes with 95% confidence intervals are 
derived for all continuous measures. For binary measures, 
odds ratio and chi-square tests are converted into Cohen’s 
d per Chinn S (2000) [21], which allow the use of Cohen’s 
guidelines of 0.2, 0.5 and 0.8 to classify the effect size as 
small, medium or large for clinical interpretation [22]. All 
analyses are two tailed with type I error <0.05. All analyses 
were performed using SAS, version 9.4 [23].
4. Results
4.1 Characteristics of the Study Population  
The mean age of the cohort at baseline (N=428) was 80.4 
(sd = 9.6; range 55-102). Women constituted 64% of the 
sample. The population was 99% Caucasian, reflecting the 
demographics of the region. The majority was single (68%). 
Most participants (75%) had been skilled or unskilled la-
borers. Although they were living in retirement facilities, 
their level of independence varied. Most required long-term 
care (71%). Others had short stays for rehabilitation (12%) 
or lived relatively independently in apartments or cottages 
(7%). Few facilities had dementia units and only 11% of 
the participants resided there. (Table 1)



























Skilled Laborer 43 10
Laborer 145 34
Homemaker 50 12
Not in workforce 22 5
Residence
Dementia Unit 47 11
Assisted/Independent 28 7
Long Term Care 302 71





Private pay 54 13
Note: * N = 428
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4.2 Psychiatric Disorders 
Psychiatric history was present in 219 (51%). In Figure 1, 
some disorders have been clustered due to the sample size. 
For example, mood disorders include major depressive and 
bipolar disorders. Mood/Anxiety disorders due to a general 
medical condition were common 54(13%). Anxiety disor-
ders 32(8%) include generalized anxiety disorder and panic 
disorder. Schizophrenia includes schizoaffective disorders, 
diagnosed in 23(5%). Adjustment disorders 53 (12%) in-
clude the different subtypes: anxiety, depression and con-
duct. Some disorders are noteworthy. Persistent Complex 
Bereavement Disorder occurred in 38 (9%) of participants. 
Personality Disorders 17 (4%), Alcohol Use Disorder 
32(8%), Other Substance Use Disorder 3(0.7%) and Gam-
bling Disorder 1 (0.2%) continue in late life. Hoarding Dis-
order was diagnosed in 5 (1%) of participants. 
Figure 1. Psychiatric Disorders (N)
Major 218 (51%) and mild 102 (24%) neurocognitive 
disorders were present. Of these 67 (16%) were unable 
to complete the MMSE. The neurocognitive disorders 
were due to Alzheimer’s 114 (27%), Vascular 71(17%), 
Lewy Body Disease 16(4%), Parkinson’s 47(11%), Fron-
tal Temporal Lobar Degeneration (FTLD) 8(2%) and a 
mixed group 53 (12%). The mixed group of neurocog-
nitive disorders included: infections (Creutzfeldt Jacob 
Disease-CJD), Huntington’s disease (Figure 2). Those 
who met criteria for a major neurocognitive disorder were 
significantly more likely to have a psychiatric history (X2 



















Figure 2. Neurocognitive Disorders (N)




















































































Figure 3. Pharmacotherapy (N)
The most common systems affected by moderate to se-
vere pathology were Central Nervous System (CNS) 175 
(41%), cardiac 294 (64%), renal 131(31%), rheumatologic 
214 (50%), respiratory 122 (29%), gastrointestinal disease 
48(21%). Specific medical conditions observed included 
chronic pain 58 (14%), cancer 100 (23%), macular degen-
eration 43 (10%), severe hearing loss 34 (8%), Parkinson’s 
Disease 60 (14%), obesity 56 (13%) sleep apnea 33 (7.7%), 
hematological conditions requiring blood transfusions 10 
(2%), pseudobulbar affect 4 (1%), restless leg syndrome 
16 (4%) and normal pressure hydrocephalus 9 (2%). Four 
or more co-morbid medical conditions were present in109 
subjects (25%) (Figure 3). 
4.4 Correlations with Medical Conditions 
Participants with macular degeneration were more likely 
to be agitated as measured by higher scores on the PAS (X2 
5.2, df =1 p = 0.02, d=0.22: 95%CI 0.03-0.41). In fact, 
42.9% of those with macular degeneration were agitated 
compared to 26.2% without macular degeneration. The 
strongest correlation with macular degeneration was with 
increasing age (t = -5.3, df = 426 p < 0.0001, d=0.51: 95% 
CI 0.32-0.71) with their mean age being 87.6 (sd=6.92) 
for those with macular degeneration compared to a mean 
age of 79.6 (sd=9.54) for this without. Participants with 
severe hearing impairment were more likely to be agitated 
as measured by higher scores on the PAS (X2 4.9, df =1 p 
= 0.03, d=0.21: 95%CI 0.02-0.40) and performed below 
the norm on the MMSE (X2 3.8, df =1; p = 0.05, d=0.19: 
95%CI 0.00-0.38). Those suffering chronic pain also per-
formed below the norm on the MMSE (X2 5.7, df =1; p = 
0.02, d=0.23: 95%CI 0.03-0.42). 
4.5 Reasons for Referral
The common reasons for referral were behavioral distur-
bances 173 (40%), depression 149 (35%), altered mental 
DOI: https://doi.org/10.30564/jgm.v1i2.1840
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status 77 (18%), psychotic symptoms (hallucinations or 
delusions) 72 (18%), adjustment to loss and change 42 
(10%) and anxiety 33 (8%). The prominent behavioral 
disturbances were: unrelenting vocalizations 25 (6%), ag-
gression or abuse 100 (23%), intrusive wandering 33 (8%), 
agitation 72 (17%), inappropriate sexual behavior 23 (5%) 
and resisting care 40 (9%). 
4.6 Treatments
Pharmacotherapy 
The psychiatrist (SS), introduced to participants already 
receiving a myriad of psychotropic medications, took an 
active role in medication adjustments. 
At baseline the majority were taking antidepressants 
335 (78%). Antipsychotic agents were prescribed to 272 
(64%). Participants on antipsychotic agents were more 
likely to die (X2 = 8.5, df 1, p = 0.004, d=0.28: 95%CI 
0.09-0.47) than those who were not. This pattern was not 
observed with opioid analgesia (X2 = 0.69, df 1, p = 0.40, 
d=0.08: 95%CI -0.11-0.27). Mood stabilizers 65(15%) 
were useful for participants with bipolar disorders and for 
behavior disorders that were refractory to second-gener-
ation antipsychotics. The memory enhancers 162 (38%) 
were less often prescribed. ‘Sleep Aids’ 47 (11%) in-
cluded trazodone, mirtazapine, melatonin. Only if these 
failed, non-benzodiazepine hypnotics were prescribed. 
Medications specific for neurological conditions were also 
administered: Seizure Disorder 29 (7), Parkinson’s disease 
45 (11) and Restless Leg Syndrome 22(5). (Figure 4).
Psychotherapy 
Participants could engage in the individual therapy 132 
(31%) 
(e.g. supportive/educational, cognitive behavioral, in-
sight oriented, interpersonal psychotherapy). Couples 
were treated 29 (7%). Families received interventions 56 
(13%). All team members used behavioral modification 




















Figure 4. Pharmacotherapy (N)
4.7 Correlations of Cognitive Status, Mood, Agi-
tation and Function 
The participants with major neurocognitive disorder were 
more likely to be dependent (Mean 37, sd=24.8) com-
pared to those without impairment (Mean 57, sd=27.8 p 
< 0.0001, d=0.76: 95%CI -0.56-0.96). A similar pattern 
was observed for agitation. Participants with major neuro-
cognitive disorder were more likely to be agitated (Mean 
6.4, sd=5.4) than those who were normal or only mildly 
impaired (Mean 2.1, sd=3.8 p < 0.0001; d=0.92: 95%CI 
0.72-1.12). Participants with major neurocognitive dis-
order were also more likely to be depressed (Mean 7.3, 
sd=5.8) than those who were normal or only mildly im-
paired (Mean 5.9, sd=4.4, p=0.003, d=0.27: 95%CI 0.08-
0.46).
4.8 Cognitive Status At Baseline and Change 
Over Time (MMSE) 
Baseline MMSE scores for the cohort were normal 65 
(16%), mild 134 (32%), moderate 136 (32%), severe 18 
(4%) and so severe that the MMSE could not be complet-
ed 67(16%). The mean score was 20.9 (N =353, sd=5.96). 
The McNemar’s test was used to assess if the proportion 
of patients impaired varied significantly at different time 
points when compared to baseline. While a significant 
difference from baseline was observed at 26 weeks (Mc-
Nemar’s S=4.00, p=0.046, d=0.58: 95%CI 0.01-1.14), 
(N=26), this effect was driven by 4 patients with nor-
mal MMSE scores who declined. This change was not 
observed at 52 or 78 weeks. Since it is well known that 
DOI: https://doi.org/10.30564/jgm.v1i2.1840
Table 2. Cognitive Transitions: Weeks 26 & 52 vs. Base-
line Using MMSE Categories*
Baseline Week 26 % Baseline Week 52 %
Normal Stable 34 Normal Stable 46
Mild 54 Mild 36
Moderate 17 Moderate 18
Severe 0 Severe 0
Mild Stable 67 Mild Stable 50
Moderate 22 Normal 20
Severe 11 Moderate 25
Moderate Stable 50 Severe 5
Mild 30 Moderate Stable 47
Severe 20 Normal 6
Severe Stable 100 Mild 29
Severe 18
Note: * Mini-Mental State Exam (MMSE) Scores range from 0-30. Here 
are the commonly used cut scores for severity: normal 27-30; mild 21-
26, moderate >10-20 and severe ≤ 10. Improvement is highlighted in 
grey.
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change in cognitive function occurs gradually, we elected 
to search for patterns in the data descriptively. This in-
spection revealed that most seniors remain stable (55%). 
Some become severely impaired overtime (11%) and 18% 
improved. (Table 2).  
4.9 Geriatric Depression Scale Scores at Baseline 
and Overtime 
As many as 173 (48%) had scores >5 on the GDS with 
mean =6.35, sd = 4.11. For the 26 patients with both base-
line and 26 weeks, using the continuous scale, we record-
ed a significant reduction in GDS scores from baseline 
(mean=6.35, sd=4.11) to 26 weeks (mean=4.50, sd=3.64) 
(t(25)=2.48, p=0.02, d=0.99: 95%CI 0.39-1.56). Of de-
pressed individuals only 35% improved over a 6-month 
period. At weeks 52 and 78, no further improvement was 
observed.
4.10 Pittsburgh Agitation Scale Scores at Baseline 
and Overtime
The frequency of agitation at baseline was 117 (27.9%). 
By week 26, 80% of the agitated patients transitioned to 
a non-agitated state, scores below 4 on the PAS or a 50% 
reduction from baseline (McNemar’s S= 12.0, p=0.0005, 
d=1.20: 95%CI 0.66-1.71). Similarly by week 52 McNe-
mar’s S= 12.0, p=0.0005,d=1.20,95%CI 0.66-1.71 and 78, 
100% of the agitated patients transitioned to a non-agitat-
ed state (McNemar’s S= 11.27, p=0.0008, d=1.17: 95%CI 
0.63-1.68). For the 34 patients with both baseline and 26 
weeks, using the continuous scale, there was a signifi-
cant reduction in PAS scores from baseline (mean=5.38, 
sd=4.95) to 26 weeks (mean=2.97, sd=3.91) (t(33)=3.00, 
p=0.005, d=1.04: 95%CI 0.51-1.54).
4.11 Barthel Index Scores: Activity of Daily Liv-
ing at Baseline and Overtime 
Of the 414 participants, the mean score on the Barthel 
Index was 47, sd=28 with 48.3% of the cohort being in-
dependent. A subset of the population was followed over 
time with mean scores of 41.4 (sd=32.39, 44.8 (sd=32.03), 
and 40.3 (sd=20.59) over weeks 26, 52, and 78 respec-
tively. Decline in function at week 26 was not statistically 
significantly different (t(26)=1.66, p=0.11, d=0.65: 95%CI 
-0.16-1.42) but at 52 and 78 was statistically signifi-
cant (t(48)=3.00, p=0.0042, d=0.87: 95%CI 0.26-1.45; 
t(35)=4.24, p=.0002, d=1.43: 95%CI 0.77-2.04) Focusing 
on independent status when compared to baseline, by 
week 52, 35.5% (McNemar’s S = 6.23, p=0.013, d=0.79: 
95%CI 0.19-1.36) and by week 78, 59.1% transitioned 
to a dependent state (McNemar’s S = 13.00, p=0.0003, 
d=1.04: 95%CI 0.42-1.62).  
4.12 Reimbursement for Telepsychiatry Services
The participants paid for the services primarily through 
state or federal funding (75%). Two other sources of pay-
ment were personal health insurance (13.5%) or private 
pay (12.2%).  
5. Discussion
Telepsychiatric evaluation using DSM-V criteria supple-
mented by assessment tools yielded a full range of diagno-
ses and revealed interactions with medical comorbidities 
similar to office practice. The frequency of the various 
neurocognitive disorders in our cohort followed the same 
pattern reported in the literature: Alzheimer’s Disease, 
cerebrovascular disorders, lewy body spectrum disorders 
and FTLD [24-26]. Rare causes of neurocognitive disorders 
were also diagnosed: CJD [27] and Huntington Disease [28]. 
Notable interactions with co-morbid medical conditions 
include a higher levels of agitation in participants with 
macular degeneration and severe hearing impairment. 
Those with chronic pain and hearing impairment per-
formed below the norm on the MMSE. 
Telepsychiatry permitted our participants to receive a 
variety of therapies with or without medication manage-
ment. Individuals and couples responded to an eclectic 
approach to psychotherapies dependent on their needs 
(cognitive behavioral, interpersonal, insight oriented and 
supportive/educational). Family interventions varied from 
a single consultation to facilitate treatment post discharge 
to more commonly assisting families to manage caretaker 
burden. Psychopharmacology lends itself well to telepsy-
chiatry. We used an evidence-based approach (reference 
to recent scientific publications, participants’ medical 
records, laboratory and imaging) to plan treatment. For 
example, acetylcholinesterase inhibitors have been report-
ed to be more effective in mild neurocognitive disorders 
[29]. Improved diagnostic precision resulted in a change of 
treatment for pseudobulbar affect [30]. The prescription of 
second-generation antipsychotics in seniors increases mor-
tality rate. However, untreated psychosis in patients with 
Alzheimer’s disease is strongly associated with nursing 
home admission and time to death when untreated [18]. The 
FDA Summary Basis of Approval reports for 28 pharma-
cological agents approved between 1990 and 2011 found 
that overall mortality risk was significantly associated 
with psychiatric diagnosis but was not further increased 
when patients were assigned to psychotropic agents ver-
sus placebo [31]. The current treatment recommendation for 
psychosis and agitation in late life remains antipsychotics 
DOI: https://doi.org/10.30564/jgm.v1i2.1840
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[32]. Similar to our study, antidepressants were the most 
frequently prescribed psychotropic medication [33].
Lower scores on the MMSE were associated with de-
pression, agitation, and dependence at baseline confirming 
earlier research. MMSE scores over time did not yield 
clear evidence of change in this 3-year study using stan-
dard statistical tools. In one study, the mean age at which 
the cognitively unimpaired transition to subjective mem-
ory complaints was 81.5 years. 55% of that cohort were 
diagnosed with mild cognitive impairment over a further 
9 year period [34]. When we applied a purely descriptive 
approach to our data, variations were identified. In fact, 
most participants remained stable, some became severe-
ly impaired and some improved. Cognitive status shows 
variation even during this relatively short time span and 
allows an opportunity for intervention. The reasons for the 
improvements require research confirmation: treating the 
underlying medical condition, refinement of medication 
regime, reduction in agitation, decrease in family dysfunc-
tion, improved mood. 
Depression was common in our cohort. GDS scores 
decreased significantly from baseline to 26 weeks but not 
beyond. Only 35% of depressed individuals responded to 
treatment over 6 months replicating findings reported from 
the face-to-face Prevention of Suicide in Primary Care El-
derly: Collaborative Trial (PROSPECT) [35]. The latter study 
provides an alternative health care approach (family physi-
cian and nurse manager) effective in decreasing depressed 
mood, suicidal ideas, morbidity and mortality [35-37].  
Agitation at baseline affected 28% of participants. By 
52weeks, 100% had significantly reduced PAS scores. 
Agitation is one of the variables found to most impact 
caretaker burden [38] and therefore a modifiable factor pre-
venting or postponing admission to a retirement facilities.
Dependence at baseline was common. Further decline 
in activities of daily living was particularly noticeable at 
52 and 78 weeks. Maintenance of mobility is another pos-
sible modifiable factor that may allow seniors to remain in 
the community. Research has demonstrated that vigorous 
physical activity improves memory and protects against 
cardiovascular risk factors; whereas a sedentary lifestyle 
is associated with decline in executive function [39].
One study reported that a telemedicine program re-
ceived comparable insurance reimbursement to in-person 
care with a mixture of 45% private, 50% medicare, and 
5% self-pay [40]. In our study, insurance reimbursement for 
IP and telepsychiatry was similar, but most of the burden 
was on government payers.
Strengths: (1) This is a prospective longitudinal cohort 
study of 428 seniors using telepsychiatry to recreate best 
geriatric psychiatry office practices for those underserved 
in rural areas. (2) The same psychiatrist completed the 
evaluations and scored the instruments, which avoided 
problems arising from poor inter-rater reliability. (3) 
These results are generalizable to seniors in other settings 
with similar demographics. Generalizability was further 
improved by the adoption of non-restrictive eligibility cri-
teria. (4) Our results treating seniors via telepsychiatry are 
often consistent with the literature involving participants 
seen face-to-face.  
Limitations: The study does not include a control group 
nor measure cost effectiveness nor does it examine the 
efficacy of any specific psychotherapeutic intervention. 
Brenes et al. 2015 addressed both these limitations in her 
a randomized control study comparing “telephone” deliv-
ered cognitive behavior therapy (CBT) with non-directive 
supportive therapy for older adults with generalized anx-
iety disorder with CBT proving superior [41]. The attrition 
of subjects over time due to death, discharge and signifi-
cant physical decompensation resulted in smaller sample 
sizes by study year 3.
6. Conclusions
To our knowledge this the first longitudinal study of adults 
in late life living in rural retirement communities that 
demonstrates the feasibility of offering a full complement 
of geriatric psychiatry services via telepsychiatry. This 
study contributes to our understanding of the correlation 
of cognitive status, mood, agitation and dependence. It 
highlights the need for a new approach to health care 
delivery (i.e. telepsychiatry) to stem the decline in depen-
dence, manage refractory depression and maintain cog-
nitive resilience for seniors who are underserviced both 
in rural or urban areas with the aim of extending their 
community living. This study argues for further research 
evaluating cost effectiveness of Telepsychiatry in seniors 
to support demands for a more inclusive payment policy 
from both managed care and government funding bodies.
Acknowledgments
This research did not receive any funding from agencies 
in the public, commercial or not-for-profit sectors. 
We wish to acknowledge Norman Leopold, D.O. for 
his contribution in editing the final versions of the manu-
script.
We wish to acknowledge Kevin Caputo, M.D. who 
was instrumental in organizing the structure to permit the 
study execution.
Presentation 
Steinberg Susanne I, Gallop Robert, Jani, Shraddha, Iqbal 
DOI: https://doi.org/10.30564/jgm.v1i2.1840
30
Journal of Geriatric Medicine | Volume 01 | Issue 02 | July 2019
Distributed under creative commons license 4.0
Syed, Mohammed Adil, Singh Harvinder, Bogner Hillary 
R. Telepsychiatry for Geriatric Residents in Rural Nursing 
Homes. The Journal of the Alzheimer’s Association, July 
2014, Vol.10, Issue 4, Supplement, P768.  
References
[1] Shore JH. Telepsychiatry: videoconferencing in the 
delivery of psychiatric care. Am J Psychiatry, 2013, 
170(3): 256-262.
[2] Shore JH, Mishkind MC, Bernard J, et al. A lexicon 
of assessment and outcome measures for telemental 
health. Telemed J E Health, 2014, 20(3): 282-292.
[3] Hilty DM, Ferrer DC, Parish MB, Johnston B, Cal-
lahan EJ, Yellowlees PM. The effectiveness of tele-
mental health: a 2013 review. Telemed J E Health, 
2013, 19(6): 444-454.
[4] Morland LA, Mackintosh MA, Greene CJ, et al. 
Cognitive processing therapy for posttraumatic stress 
disorder delivered to rural veterans via telemental 
health: a randomized noninferiority clinical trial. J 
Clin Psychiatry, 2014, 75(5): 470-476.
[5] Gentry MT, Lapid MI, Rummans TA. Geriatric Tele-
psychiatry: Systematic Review and Policy Consider-
ations. The American Journal of Geriatric Psychiatry, 
2019, 27(2): 109-127.
[6] Parikh M, Grosch MC, Graham LL, et al. Consumer 
Acceptability of Brief Videoconference-based Neu-
ropsychological Assessment in Older Individuals 
with and without Cognitive Impairment. The Clinical 
neuropsychologist, 2013, 27(5): 808-817.
[7] Vahia IV, Ng B, Camacho A, et al. Telepsychiatry for 
Neurocognitive Testing in Older Rural Latino Adults. 
The American Journal of Geriatric Psychiatry, 2015, 
23: 666-670.
[8] Timpano F, Pirrotta F, Bonanno L, et al. Videocon-
ference-Based Mini Mental State Examination: A 
Validation Study. Telemedicine and e-Health. 2013, 
19(12): 931-937.
[9] Cullum CM, Hynan LS, Grosch M, et al. Tele-
neuropsychology: Evidence for Video Teleconfer-
ence-Based Neuropsychological Assessment. Journal 
of the International Neuropsychological Society, 
2014, 20(10): 1028-1033.
[10] Martin-Khan, M. Flicker, L. Woooton, R. et al. The 
Diagnostic accuracy of telegeriatrics for the diag-
nosis of dementia via videoconferencing. Journal 
of American Medical Director Association, 2012, 
13(487): e419-424.
[11] Poon P, Hui E, Dai D, Kwok T, Woo J. Cognitive 
intervention for community-dwelling older persons 
with memory problems: telemedicine versus face-to-
face treatment. 2005, 20(3): 285-286.
[12] Rabinowitz T, Murphy KM, Amour JL, Ricci MA, 
Caputo MP, Newhouse PA. Benefits of a telepsychi-
atry consultation service for rural nursing home resi-
dents. Telemed J E Health, 2010, 16(1): 34-40.
[13] Egede LE, Gebregziabher M, Walker RJ, Payne EH, 
Acierno R, Frueh BC. Trajectory of cost overtime 
after psychotherapy for depression in older Veterans 
via telemedicine. Journal of Affective Disorders, 
2017, 207: 157-162.
[14] Weiner MF, Rossetti HC, Harrah K. Videoconference 
diagnosis and management of Choctaw Indian de-
mentia patients. Alzheimer's & Dementia, 2011, 7(6): 
562-566.
[15] Egede LE, Acierno, R. Knapp, RG. Lejuez, C. Psy-
chotherapy for depression in older veterans via tele-
medicine: a randomized, open label, non inferiority 
trial. Lancet Psychiatry, 2015, 2(8): 693-701.
[16] Choi NG, Marti CN, Bruce ML, Hegel MT, Wilson 
NL, Kunik ME. Six-month postintervention depres-
sion and disability outcomes of in-home telehealth 
problem-solving therapy for depressed, low-income 
homebound older adults. 2014, 31(8): 653-661.
[17] Lichstein KL, Scogin F, Thomas SJ, DiNapoli EA, 
Dillon HR, McFadden A. Telehealth Cognitive 
Behavior Therapy for Co-Occurring Insomnia and 
Depression Symptoms in Older Adults. Journal of 
Clinical Psychology, 2013, 69(10): 1056-1065.
[18] Hilty DM, Rabinowitz T, McCarron RM, et al. An 
Update on Telepsychiatry and How It Can Leverage 
Collaborative, Stepped, and Integrated Services to 
Primary Care. Psychosomatics, 2018, 59(3): 227-
250.
[19] Rosen J, Burgio L. Killar M. et al. The Pittsburgh 
Agitation Scale: A User Friendly instrument for rat-
ing agitation in dementia patients for the clinician. 
Am J Geriatric Psychiatry, 1994, 2: 52-59.
[20] Mahoney F, Barthel D. Functional Evaluation: The 
Barthel Index. Maryland State Medical Journal, 
1965: 62-65.
[21] Chinn S. A simple method for converting an odds ra-
tio to an effect size for use in meta-analysis, Statistics 
in Medicine. Statistics in Medicine, 2000, 19: 3127-
3133.
[22] Cohen J. Statistical power analysis for the behavioral 
sciences. 2nd ed. Hillsdale, New Jersey: Lawrence 
Erlbaum Associates, 1988.
[23] SAS Institute Inc. SAS® 9.4 Language Reference: 
Concepts (5th ed. Cary, NC: SAAS Institute Inc., 
2015.
[24] Mann DAM, Snowden, J. Frontotemporal lobar de-
generation: Pathogenesis, pathology and pathways to 
phenotype. Brain Pathology, 2017, 23: 723-736.
DOI: https://doi.org/10.30564/jgm.v1i2.1840
31
Journal of Geriatric Medicine | Volume 01 | Issue 02 | July 2019
Distributed under creative commons license 4.0
[25] Graff-Radford, J. Aakre, J. Savica, R. Boeve, B. et 
al. Duration and Pathologic Correlates of Lewy Body 
Disease. JAMA neurology, 2017, 74(3): 310-315.
[26] Sachdev PL, JW. Crawford, JD. Mellon, L. STROK-
OG (stroke and cognition consortium): An inter-
national consortium to examine the epidemiology, 
diagnosis and treatment of neurocognitive disorders 
in relation to cerebrovascular disease. Alzheimer’s & 
Dementia: Diagnosis, Assessment & Disease Moni-
toring, 2017, 7: 11-23.
[27] Sim V. Prion Disease: Chemotherapeutic Strategies. 
Infectious Disorders - Drug Targets, 2012, 12(2): 
144-160.
[28] Rub, U. Seidel, K. Heinsen, H. Vonsattel, JP. den 
Dunnen,WF. Korf, HW. Huntington’s disease (HD): 
the neuropathology of a multisystem neurodegener-
ative disorder of the human brain. Brain Pathology, 
2016, 26: 726-740.
[29] Cavallo MS, A. Perucchini, ML. Benefits of Cogni-
tive Treatments Administered to Patients Affected by 
Mild Cognitive Impairment / Mild Neurocognitive 
Disorder. Drug Development Research, 2016, 77: 
444-452.
[30] Cummings JL, Lyketsos CG, Peskind ER, et al. Ef-
fect of Dextromethorphan-Quinidine on Agitation 
in Patients With Alzheimer Disease Dementia: A 
Randomized Clinical Trial. JAMA : the journal of the 
American Medical Association, 2015, 314(12): 1242-
1254.
[31] Khan A, Faucett J, Morrison S, Brown WA. Compar-
ative mortality risk in adult patients with schizophre-
nia, depression, bipolar disorder, anxiety disorders, 
and attention - deficit / hyperactivity disorder partic-
ipating in psychopharmacology clinical trials. JAMA 
Psychiatry, 2013, 70(10): 1091-1099.
[32] Devanand DP. Psychosis, agitation, and antipsychot-
ic treatment in dementia. Am J Psychiatry, 2013, 
170(9): 957-960.
[33] Simoni Wastila L, Wei YJ, Luong M, et al. Quality 
of psychopharmacological medication use in nursing 
home residents. Res Social Adm Pharm, 2014, 10(3): 
494-507.
[34] Kryscio RJ, Abner EL, Cooper GE, et al. Self-report-
ed memory complaints: implications from a longitu-
dinal cohort with autopsies. Neurology, 2014, 83(15): 
1359-1365.
[35] Alexopoulos GS, Reynolds CF, 3rd, Bruce ML, et al. 
Reducing suicidal ideation and depression in older 
primary care patients: 24-month outcomes of the 
PROSPECT study. Am J Psychiatry, 2009, 166(8): 
882-890.
[36] Gallo JJ, Morales KH, Bogner HR, et al. Long term 
effect of depression care management on mortality in 
older adults: follow-up of cluster randomized clinical 
trial in primary care. BMJ, 2013, 346: f2570.
[37] Katon WJ, Lin EH, Von Korff M, et al. Collaborative 
care for patients with depression and chronic illness-
es. N Engl J Med., 2010, 363(27): 2611-2620.
[38] Terum TA, JR. Rongve, A. Svendsboe, EJ. The rela-
tionship of specific items on the Neuropsychiatric In-
ventory to caregiver burden in dementia: a systematic 
review. International journal of geriatric psychiatry, 
2017.
 DOI: 10.1002/gps.4704
[39] Steinberg S, Sammel M, Harel B, et al. Exercise, 
Sedentary Pastimes and Cognitive Performance in 
Healthy Adults. American Journal of Alzheimer’s 
Disease & Other Dementias, 2015, 30(3): 290-298.
[40] Tso JV, Farinpour R, Chui HC, Liu CY. A Multidisci-
plinary Model of Dementia Care in an Underserved 
Retirement Community, Made Possible by Telemedi-
cine. Frontiers in Neurology, 2016.
[41] Brenes GA, Danhauer SC, Lyles MF, Hogan PE, 
Miller ME. Telephone-delivered cognitive behavioral 
therapy and telephone-delivered nondirective sup-
portive therapy for rural older adults with generalized 
anxiety disorder: A randomized clinical trial. JAMA 
Psychiatry, 2015.
DOI: https://doi.org/10.30564/jgm.v1i2.1840
